Millions of Americans Decline Second Dose of Experimental mRNA COVID-19 Vaccines
By the end of April 2021, more than five million people in the United States, or about eight percent of…
Demand for COVID-19 Vaccines Declines As Eligibility Expands
As eligibility for Emergency Use Authorization (EUA) COVID-19 vaccines expands to people 16 years and older, many counties in the…
Dentists, Optometrists, Podiatrists Can Now Administer COVID-19 Vaccines in the U.S.
The U.S. Department of Health and Human Services (HHS) has announced that the agency is amending an emergency declaration under…
Pfizer’s Experimental COVID-19 Vaccine 90 Percent Effective?
The German biotech firm BioNTech SE issued a joint press release with its American partner Pfizer, Inc. on Nov. 9,…
CDC Gives States COVID-19 Vaccination Program “Playbook”
The U.S. Centers for Disease Control (CDC) created a national COVID-19 Vaccine Program Playbook for state, territorial and local public…
NVIC’s Online Vaccine Conference Rebroadcast This Weekend by Popular Demand
There was a young man walking down a deserted beach just before dawn. In the distance he saw a frail…
China Administers Unlicensed Experimental COVID-19 Vaccines to Its Citizens
China is the first country in the world to vaccinate its citizens with experimental COVID-19 vaccines that are still undergoing…
U.S. Troops Will Be Among the First to Get COVID-19 Vaccine
Senior White House officials reported that United States service members would be among the first Americans to receive a COVID-19…
Israeli Woman Treated with COVID-19 “Passive Vaccine”
Hadassah Medical Center in partnership with the Israeli biotechnology company Kamada Ltd. in Jerusalem, Israel treated its first COVID-19 patient…
Live Tuberculosis “Vaccine” Being Tested as a Treatment for COVID-19 Infections
Story Highlights Researchers at Texas A&M University and five other academic institutions have begun a phase 4 clinical trial re-purposing…